Mini-Organs reveal why gut drug fails some kids
NCT ID NCT07400783
First seen Feb 10, 2026 · Last updated May 25, 2026 · Updated 15 times
Summary
This study looks at why children with short bowel syndrome respond differently to the drug teduglutide. Researchers will grow mini-intestines (organoids) from tissue samples taken during routine surgery. They will then test the drug on these organoids in the lab to see how they change. No new treatments are given to the children themselves. The goal is to understand the biology behind the different responses and help personalize future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME (SBS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Aou Meyer IRCSS
RECRUITINGFlorence, Florence, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.